lentinan has been researched along with Local Neoplasm Recurrence in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T; Iijima, S; Kato, T; Kikkawa, N; Kimura, Y; Kurokawa, E; Matsuura, N; Naoi, Y; Tanigawa, T; Tsujie, M; Yamamoto, H | 2 |
| Atomi, Y; Kusano, M; Mitsumori, N; Nakajima, M; Nimura, H; Suzuki, S; Tokunaga, A; Tsukagoshi, S; Yoshiyuki, T | 1 |
| Kashimura, H; Kashiwagi, H; Mitsumori, N; Nimura, H; Takahashi, N; Takayama, S; Yanaga, K | 1 |
| Taguchi, T | 1 |
| Goto, S; Kera, J; Sakai, S; Soma, GI; Suma, Y; Takeuchi, S | 1 |
| Fujimoro, S; Ishigami, H; Ogawa, K; Okui, K | 1 |
| Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Masubuchi, K; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K | 1 |
| Chihara, G | 1 |
3 trial(s) available for lentinan and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Humans; Lentinan; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pilot Projects; Pyridines; Stomach Neoplasms; Survival Rate; Tegafur | 2003 |
[S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Humans; Lentinan; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Quality of Life; Stomach Neoplasms; Survival Rate; Tegafur | 2006 |
[Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Gastrointestinal Neoplasms; Humans; Lentinan; Male; Middle Aged; Neoplasm Recurrence, Local; Polysaccharides | 1983 |
6 other study(ies) available for lentinan and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Immunocompetence; Lentinan; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Silicates; Stomach Neoplasms; Titanium | 2003 |
[TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
Topics: Adjuvants, Immunologic; Adult; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Female; Humans; Lentinan; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pyridines; Stomach Neoplasms; Tegafur | 2003 |
A case report of recurrent cervical cancer which responded to a combination of biological therapies.
Topics: Adult; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Immunologic Factors; Lentinan; Lymphocytes, Tumor-Infiltrating; Neoplasm Recurrence, Local; Neoplasm Staging; Sizofiran; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1994 |
[Relationship between prolonged life span and changes of serum IAP and albumin induced by the therapy of lentinan plus tegafur in inoperable and recurrent gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Life Tables; Neoplasm Proteins; Neoplasm Recurrence, Local; Serum Albumin; Stomach Neoplasms; Tegafur | 1992 |
[Successful treatment of a patient with recurrent ovarian cancer by lentinan combined with intraarterial 5FU].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Lentinan; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction | 1989 |
[Evaluation and consideration of BRM-BRM and HDP (host defense potentiators)].
Topics: Adjuvants, Immunologic; Humans; Killer Cells, Natural; Lentinan; Lymphokines; Neoplasm Recurrence, Local; Neoplasms | 1988 |